These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6036390)

  • 1. Cutaneous hypersensitivity and desensitization to mechlorethamine in patients with mycosis fungoides lymphoma.
    Waldorf DS; Haynes HA; Van Scott EJ
    Ann Intern Med; 1967 Aug; 67(2):282-90. PubMed ID: 6036390
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivity.
    Constantine VS; Fuks ZY; Farber EM
    Arch Dermatol; 1975 Apr; 111(4):484-8. PubMed ID: 1122150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance.
    Van Scott EJ; Kalmanson JD
    Cancer; 1973 Jul; 32(1):18-30. PubMed ID: 4577503
    [No Abstract]   [Full Text] [Related]  

  • 4. Responses of mycosis fungoides to intensive external treatment with nitrogen mustard.
    Van Scott EJ; Winters PL
    Arch Dermatol; 1970 Nov; 102(5):507-14. PubMed ID: 5474113
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical mechlorethamine therapy for mycosis fungoides.
    Price NM; Constantine VS; Hoppe RT; Fuks ZY; Farber EM
    Br J Dermatol; 1977 Nov; 97(5):547-50. PubMed ID: 588466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of mycosis fungoides with ointment-based mechlorethamine.
    Price NM; Deneau DG; Hoppe RT
    Arch Dermatol; 1982 Apr; 118(4):234-7. PubMed ID: 7065680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data.
    Liner K; Brown C; McGirt LY
    Drug Des Devel Ther; 2018; 12():241-254. PubMed ID: 29440874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent low doses of intravenous mechlorethamine for late-stage mycosis fungoides lymphoma.
    Van Scott EJ; Grekin DA; Kalmanson JD; Vonderheid EC; Barry WE
    Cancer; 1975 Nov; 36(5):1613-8. PubMed ID: 1192353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of mycosis fungoides to topical chemotherapy with mechlorethamine.
    Ramsay DL; Parnes RE; Dubin N
    Arch Dermatol; 1984 Dec; 120(12):1585-90. PubMed ID: 6508330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimitotic, antigenic, and structural relationships of nitrogen mustard and its homologues.
    Van Scott EJ; Yu RJ
    J Invest Dermatol; 1974 Apr; 62(4):378-83. PubMed ID: 4820681
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical mechlorethamine chemotherapy. Considerations on its use in mycosis fungoides.
    Vonderheid EC
    Int J Dermatol; 1984 Apr; 23(3):180-6. PubMed ID: 6373639
    [No Abstract]   [Full Text] [Related]  

  • 12. Topical chemotherapy of mycosis fungoides.
    Grekin DA; Zackheim HS; Epstein EH
    Cutis; 1979 Nov; 24(5):543-6. PubMed ID: 520032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical mechlorethamine. Cutaneous changes in patients with mycosis fungoides after its administration.
    Price NM
    Arch Dermatol; 1977 Oct; 113(10):1387-9. PubMed ID: 911166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ointment-based mechlorethamine treatment for mycosis fungoides.
    Price NM; Hoppe RT; Deneau DG
    Cancer; 1983 Dec; 52(12):2214-9. PubMed ID: 6640491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical chemotherapy and immunotherapy of mycosis fungoides: intermediate-term results.
    Vonderheid EC; Van Scott EJ; Johnson WC; Grekin DA; Asbell SO
    Arch Dermatol; 1977 Apr; 113(4):454-62. PubMed ID: 848974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal contact sensitivity to nitrogen mustard in lesions of cutaneous T-cell lymphoma (mycosis fungoides).
    Shelley WB
    Acta Derm Venereol; 1981; 61(2):161-4. PubMed ID: 6165197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photochemotherapy and topical nitrogen mustard in the treatment of mycosis fungoides.
    du Vivier A; Vollum DI
    Br J Dermatol; 1980 Mar; 102(3):319-22. PubMed ID: 7370179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical mechlorethamine therapy for early stage mycosis fungoides.
    Ramsay DL; Halperin PS; Zeleniuch-Jacquotte A
    J Am Acad Dermatol; 1988 Oct; 19(4):684-91. PubMed ID: 3183094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous desensitization to mechlorethamine in patients with psoriasis.
    Pariser DM; Childers RC; Kechijian P; Halprin KM; Taylor JR
    Arch Dermatol; 1976 Aug; 112(8):1113-4. PubMed ID: 952529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycosis fungoides plaque stage treated with topical nitrogen mustard with and without attempts at tolerance induction: report from the Scandinavian mycosis fungoides study group.
    Molin L; Thomsen K; Volden G
    Acta Derm Venereol; 1979; 59(1):64-8. PubMed ID: 84470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.